22. Duell EA, Astrom A, Griffiths CEM, C hambon P, Voorhees 11: Human skin levels of retinoic aeid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of rctinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro.
The biologic activities of retinoic acid and 3,4-didehydroretinoic acid, two endogenous vitamin A derivatives in various tissues, were compared to their affinities for the nuclear retinoic ac.id receptors ~nd. their ability. to indu.ce transcript~onal activatlOn. Both retlnolds were eqUIpotent Inducers of differentiation of F9 teratocarcinoma cells. In a morphologic assay, using reconstructed skin, retinoic acid and 3,4-didehydroretinoic acid inhibited keratinization at a concentration of 100 nM. In cultured keratinocytes, a 50% inhibition of the production of the keratinocyte trans glutaminase enzyme was achieved with about 20 nM for both retinoids. The in vitro binding to the nuclear retinoic acid receptors a, p, and y showed that retinoic acid and 3,4-didehydroretinoic acid had almost equal affinities for the receptors with Kds ranging from 3 to 47 nM. The transcriptional activation resulting S ince the discovery of nuclear retinoic acid receptors (RARs). retinoids (vitamin A derivates) can be regarded as hormones that mediate their differentiation and morphogenetic effects by modulating the transcription of ensembles of developmentally regulated genes. In the chick embryo, two endogenous retinoids with morphogenetic properties have been identified so far: retinoic acid (RA) and 3.4-didehydroretinoic acid (ddRA) [1.2] . Because the local concentration of ddRA in the embryo is about six times higher than the concentration of RA [2] . the former compound might be even more important than RA during embryogenesis. However, it should be stressed that the mechanism of action of retinoids in the chick limb bud is not completely elucidated. For example, it has been suggested that retinoids act indirectly by inducing. perhaps at the transcriptional level [3.4] , Manuscript received April 22. 1993; accepted for publication August 13. 1993 .
This work has previously been presented in part at the SID meeting. Seattle. May 1-3. 1991 from the addition of the two retinoids to cells co-transfected with a, p, or y retinoic acid receptor expression vectors and a retinoic acid responsive element linked to the chloramphenicol acetyltransferase reporter gene was similar. Finally, it was demonstrated that retinoic acid did not metabolize to 3,4-didehydroretinoic acid, and a slow conversion of 3,4-didehydroretinoic acid into retinoic acid was not sufficient to explain the biologic effects produced by the former compound.
In conclusion, the present study demonstrates that retinoic acid and 3,4-didehydroretinoic acid have the same activity in several different test systems, but their metabolism differs depending on the cell type used. Key words: ep idermis/retino ic acid receptors/retinoids/v itMnil1 A. ] Invest Dermato/1 02: 49 -54, 1994 cells in the zone of polarizing activity to produce actual morphogens.
In epidermis, rerinoids are known to play an important role in the proliferation and differentiation of keratinocytes. So far the interest has been concentrated solely on retinoic acid and recently the metabolic conversion of retinol (ROH) into RA in cytosolic extracts from differentiating keratinocytes was established [5] . However, in human epidermis a considerable amount of ROH is converted into 3.4-didehydroretinol (ddROH) [6.7] , the putative precursor of the morphogenetic substance ddRA [2] . The epidermal concentration of ddROH is increased in several skin diseases, especially in connection with hyperproliferation [7] . Considering the conversion of ROH to ddROH in keratinocytes and the existence of specific retinol-dehydrogenases. it is possible that. as in rhe embryo, both RA and ddRA are generated locally in adult human epidermis. In the present work, using several in lIitro models of morphogenesis and differentiation, we compare the biologic properties ofRA and ddRA to their affinities for the RAR ex. P, and y receptors. Furthermore, the transcriptional activation of a reporter gene linked to a retinoic acid responsive element by RA and ddRA in combination with RARs is analyzed using co-transfection experiments.
MATERIALS AND METHODS
Chemicals RA. ddRA. and Ro 12-0586 were gifts from Holfmann-LaRoche (Basel. Switzerland). The purity ofRA and ddRA was determined by HPLC to be > 99% and > 97%. respectively. we re synthesized in CIRD Galderma. Fi gure 1 shows the structural formul as of the retinoids discussed in the tex t.
Reconstructed Skin The preparation of dermal equivalents (collagen lattices contracted by human fibrobl asts) and the method for seedin g and culturin g epidermal cells on th ese substrates were described in detail previously [8] . Briefl y, adult interfollicular epidermal cell s isolated from human breast ski n and amplified in primary culture were used. The cultures (d ermal equivalents seeded with keratinocytes) were first kept submerged for 1 week to form a conflu ent monol ayer and then rai sed on a stainless steel grid at th e air-liquid interface to produce a stratified and keratinized epithelium durin g anoth er wee k. The tissue culture medium consisted of minimal essential med ium (MEM) supplemented with 10% fetal calf serum, epidermal growth facto r (1 0 ng/ml), hyd rocortisone (0.4 fl g/ml) , and cholera toxin (10-9 M). Retinoids , in dimeth ylsulfoxide, were added to the culture medium wh en th e cultures we re at th e air-liquid interphase . Medium was changed three times wee kly . Histology was performed by staining vertica l paraffin sectio ns with haemalum-phloxin-saffron .
Differentiation ofKeratinocytes in Serum-Free Medium and Keratinocyte Transglutaminase Assay The method for determination of retinoid activi ty by the enzyme-linked immunosorbe nt assay has been described in detail previously [9] . Briefly, keratinocytes were cultured in serum-free MC DB153 tissue culture medium (ICBM , C lonetics, San Diego, C Al in 96-well clusters for 4 d in the prese nce of different retinoid concentrations, CD367, a very potent stabl e sy nth etic retinoid bein g used as a control. The amount of the membrane-bound keratinocyte transglutaminase (TGm) was th en qu antified, with out any extraction or purification step, usin g a T G mspecific monoclo nal antibody (B.C l) and a peroxidase-conju gated second T HE J O URNAL OF INVESTIGATIVE DERMATO LOGY antibody [9] . The dose-response curves obtained with th e enzyme-linked immunosorbent assay tec hn ique were eva lu ated w ith th e MlNSQ curve-fi tting program (MicroMathScientific Software, Sa lt Lake C ity, UT) run ning on an IBM Personal co mputer. The data were fi tted by nonlinear regression [9] . For ca lculations of th e retinoid co ncentratio n leading to a 50% inhibition of TGm (I C so ), th e residual activity at 10-6 M was subtracted.
Assay of Biologic Activity on F9 Cells The activatin g effect of retinoids on th e plasminoge n activator, a marker of differentia tion of F9 murine embryo nal ca rcinoma cell s, was assayed after 3 d in culture as prev iously described [1 0]. The retinoid co nce ntration inducin g 50% pl as minogen activator production (A C so ) rel ative to th e max imum of the pre-response curve was calcul ated as before [11] .
Determination of Retinoid Affinities for lX, p, and y RARs A full desc ription of th e meth od has already bee n published [1 2]. Briefl y, nuclear extracts were prepared fro m cos7 cel ls transfected with express ion vectors for human a, /1, and y RARs (y expression vector was purchased fro m La Jolla Ca ncer Research Found ation, La J olla, C Al . These extracts were incubated for 2 h with [3H] CD367 (a high-affini ty retinoid) and varyin g concentrations of unlabeled C D 367 or th e natural retinoids (i .e. , RA and ddRA) used in this study [10, 13] . The amoun t of radi olabel specifica ll y bound to RARs was separated from free li gand by high-perfo rmance size exclusio n chro matography. Competition binding curves were analyzed by the MINSQ-program and Kds were calcul ated.
." 2 ) were co-transfected with 3.4lJ.g of pCH110 and 4IJ.g of pBS. RAR (1.6IJ.g) was introduced into the cells together with Illg of RARE-tk-CAT using CaPO, co-precipitation as described (14] . After transfection, cells were maintained in medium containing charcoalstripped serum. Retinoids were added in concentrations ranging from 0.1 nM to 10 IJ.M . CAT-activity was determined after 24 hs by liquid scintillation counting [14] after normalization for jJ-galactosidase activity (15]' The retinoid concentration required to obtain half-maximal stimulation (EDso value) was calculated by non-linear regression using the MINSQ program.
Retinoid Analysis The concentrations of RA and ddRA in cultured cells and medium were determined by reversed-phase high-performance liquid chromatography using a non-hydrolytic extraction procedure. Briefly, internal standard (Ro 12-0586), ethanol (500 1J.1), phosphate-buffer, pH 4.5 (600 Ill), and butylated hydroxytoluen, was added to a test tube containing cells or medium (250 IJ.I). The samples containing cells were subjected to a 20-second burst using a Polytron homogenizer. After extraction twice with hexane rhe pooled hexane phases were evaporated and redissolved in methanol and subjected to analysis by reversed-phase high-performance liquid chromatography as described (16] . The amount of RA or ddRA was related to the volume of cells or medium and expressed aSIJ.M. The cell volume was calculated from the protein content of the samples and the known proteincell volume ratio (1 mg of cellular protein = 251J.1 of cells). The protein content was measured by a biuret technique using bovine serum albumin as protein srandard.
RESULTS

Inhibition of Keratinization in the Reconstructed Epidermis
We used the reconstructed epidermis model as a morphologic assay of the potency of retinoids to inhibit terminal differentiation. Histology of the sections allows us to determine the retinoid concentration that produces a complete inhibition of formation of granular and cornified layers (parakeratosis).
The results (Fig 2) show that a concentration of 100 nM ofRA or ddRA is sufficient to inhibit the formation of these layers, whereas only 1 nM of CD367 (see Table I ) is sufficient to produce a similar effect. 
Inhibition of Keratinocyte Transglutaminase Production in
Keratinocytes Cultured in Serum-Free Medium Because keratinocyte transglutaminase is a key enzyme of epidermal differentiation expressed in granular layers and involved in the formation of cornified layers, this marker is particularly suitable to quantify the effects of retinoids in inhibiting keratinization. In the dose-response curves obtained after plotting the amount of transglutaminase measured versus retinoid concentration, the concentration corresponding to 50% inhibition of the accumulation of the transglutaminase enzyme (IC so ) is determined. The results (Fig 3) show that transglutaminase production is inhibited with an lC so of approximately 20 11M of RA and ddRA. For comparison, the value obtained for CD367 in this assay was approximately 0.1 11M (see Table I ).
Retinoid Activity in F9 Cells As shown in Table I , the AC so are very similar for RA and ddRA: 200 nM and 180 11M, respectively, whereas only 0.6 nM is necessary in the case of CD367.
Retinoid Affinities for a, p, and y RARs In Vitro Retinoid binding ill lIitro to the RARs [13] obtained from nuclear extracts of cells transfected with a, p, and y RAR expression vectors shows that RA and ddRA bind to RARa and P with almost equal affinities, whereas RA showed higher affinity than ddRA for RARy (Table I) .
The values obtained for CD367 used as a reference showed, by comparison with RA, an affinity of the same order [13] .
Transcriptional Activation in CV-1 Cells The CAT activities in CV-l cells transfected with RARE-tk-CAT plus RARs (a, p, or y) and exposed to different concentrations of RA and ddRA are shown in Fig 4. As can be seen, the retinoid concentrations corresponding to 50% of maximum CAT activity (EDso) were 100, 100, and 20 11M, respectively, for the three receptors (a, p, and y). There was no obvious difference between RA and ddRA.
Retinoid Concentrations in Cells and Media To examine a possible degradation and metabolic intercOllversion of RA and ddRA during incubation, cells and media from the aforementioned experiments were analyzed by high-performance liquid chromatography. Table II shows the retinoid concentrations 24 h after addition of 1 J.1M of RA or ddRA. There were some notable differences between the cell lines and between the two retinoids. Keratinocytes exposed to RA contained similar amounts of retinoid when cultured submerged or at the air-liquid interface, but the fonner cells appeared to consume RA more rapidly. RA to ddRA. Divergent results were obtained after addition of ddRA. Only in the case of CV-l ce lls were significant amounts of ddRA present in the medium after 24 h, and the cellnlar retinoid concentration was less t han one quarter that observed after addition of RA. Small high-performance liquid chromatography peaks corresponding to RA were detected in all ddRA-containing samples. The RA concentration was about 10% of the ddRA value in CV -1 cells and 20% of the ddRA value in F9 cells. Relatively higher values were seen in keratinocytes, but these values correspond to only 0.5 -2% those obtained after addition ofRA. On the whole, the investigated cell lines (with the possible exception of F9) seemed to degrade ddRA at a higher rate than RA and were probably able to convert some ddRA to RA. However, the extent of ddRA to RA conversion cannot be evaluated because our authentic ddRA batch, despite re-chromatography, was contaminated with small amounts (3%) of RA, the relative contribution of which will probably increase during incubation as a result of the more rapid degradation of ddRA. • In the case of keratinocytes (KC) and F9 cells the analyzed samples were frolll the third exchange (day 3) of retinoid-containing medium .
DISCUSSION
• The values represent means of duplicate experiments. ' NO, not detected (detection limit in cells is 5 nM and in medium is 10 nM ofRA and ddRA). , For unknown reasons the RA concentration in the medium was about three times higher than at the onset of the experiment. Presumably, KC cultured at the air-liquid interface reJeasc RA back to the medium after an initial saturation occurring during the first and seco nd exchanges of RA-supplcmcntcd medium.
differentiation of epidermal keratinocytes. Our results show that RA and ddRA are equipotent inducers of F9 cell differentiation (induction of plasminogen activator) and also inhibits terminal differentiation of epidermal keratinocytes cultured at the air-liquid interface (induction of parakeratosis) at similar concentrations (summarized in Table I ). Epidermal transglutaminase, a key enzyme in terminal differentiation ofkeratinocytes, was inhibited to 50% by both RA and ddRA at concentrations (IC so ) close to the Kds for RARs . This suggests that the biologic activities of these compounds are directly related to their affinity for the receptors. One of the receptors, RARP, has previous ly been shown to be upregulated by retinoids in an autocrine loop fashion in several different types of cells [17 -20] . In mouse melanoma cells, the induction of RARP mRNA expression by RA was recently found to be a hundred-fold higher than by ddRA [21] . Using a synthetic CAT-reporter gene, regulated by the RARP-RARE, we investigated in co-transfection experiments whether RA and ddRA differently induce transciptional activation of this gene when combined with different RARs. As shown in Fig 4, ddRA is as effective as RA at inducing the CAT-reporter gene when combined with either a, p, or y RARs.
The weakest induction of CAT transcription was obtained with RARa, whereas RARP or RARy produced higher and similar inductions. The transcriptional activation by RA and ddRA of other response elements has previously been shown to be similar [22,23].
One of the first observations using RARE-tk-CAT in CV -1 cells was that the CAT-stimulation was generally higher than with t he (TREh-tk-CAT. Moreover, the EO so values obtained for RAREtk-CAT were 5 -20 times higher than previously reported for (TRE3h-tk-CAT [14] . The EO so values obtained with RARE-tk-CAT were 6-20 times higher than the binding values for RA and ddRA obtained with purified nuclear receptor proteins (Table I) . A possible explanation to this is that exogenous retinoids are more readily metabolized during cell culture than during incubation with nuclear extracts. Evidence for an extensive catabolism of ddRA was obtained in keratinocytes and F9 cells. Thus 24 h after addition of 1 J.lM ddRA to the medium only small amounts of retinoids were present in the cells (0.03 -0.3 J.lM) and no retinoids were detectable in the media. The monkey kidney epithelia l CV-l cells behaved differently; the cellular content of ddRA was the same as for other cell lines but the medium contained the expected amount (about 1 J.lM) of retinoid, suggesting that CV-1 cells have a slow metabolism of ddRA. Similarly, CV-l cells consumed little, if any, of added RA and the cellular content ofRA after 24 h (1.6 J.lM) was intermediate to that of other cell types and five times the corresponding ddRA value. The overall results suggest that i) various cell lines differ tremendously in their ability to accumulate and metabolize exogenous RA and ddRA, ii) in a given cell line RA usually accumulates to a larger extent than ddRA, and iii) re lative to RA the most extensive metabolism of exogenous ddRA occurred in human keratinocytes, i.e., cells that express the 3,4-didehydro metabolic pathway under normal conditions [6] .
Another factor that might obscure the results when comparing the biologic activities of RA and ddRA are metabolic interconver-sions that have been reported to occur at least in the chick wing bud system [2] . However, topical application of 1 J.lCi of [3H]RA to human skin for 24 h does not produce detectable levels of [3H]ddRA in epidermis (Vahlquist, unpublished observation) . Also, RA was not converted to ddRA by any of our cell lines and only smaJl amounts ofRA were detected when ddRA was added to the cultures (see Table II ). Thus we are confident that ddRA exerts its activities without first being converted to RA. This does not, however, exclude the existence of other biologically active metabolites of ddRA. To the contrary, we think this is likely the case, because in several models of epithelial differentiation ddRA was as active as RA but at cellular concentrations far below those attained with RA additions (see Table II ). Yet both compounds activate RAREs with similar potency. To further elucidate this possibility one needs to know the cellular concentrations of RA and ddRA at different time points of incubation and the time delay between the peak concentratioJ1 values and the maximal expression of biologic activity.
In conclusion, we have shown that ddRA and RA bind to the RARs with similar affinities, induce transcriptional activation with the same dose dependency, and exert similar effects in models of epidermal differentiation. Thus, ddRA appears-alike RA-to fulfi ll the requirements of an active vitamin A metabolite. Considering the possibility that under physiologic conditions many types of epithelial cells of human origin produce both RA and ddRA, one might predict that the regulation of gene expression by vitamin A depends not only on the composition and amounts ofRARs but also on the tissue-specific production of these two ligands. Importantly, we show that RA is not metabolized into ddRA by the cells but a minor conversion of ddRA to RA cannot be ruled out. It remains to be determined whether these two hormonal forms of vitamin A behave similarly in the embryo, for instance in transgenic animals bearing RARE-lacZ constructs.
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